Handbook Of The Vulnerable Plaque

Since publication of the First Edition, advances in the diagnosis and prevention and treatment strategies of the vulnerable plaque have necessitated this greatly expanded second edition. With several new chapters covering mainly diagnostic and treatment options, The Handbook of the Vulnerable Plaque will remain the benchmark text for all interventi

Although most in the field would agree that the vulnerable plaque is an important topic, there is still considerable disagreement over the precise meaning of this term and the related terms high-risk plaque and thrombosis-prone plaque. Until now very few books have been available that both define this rapidly evolving field and provide authoritative information for diagnosis and treatment. A comprehensive guide to understanding the many complexities of the vulnerable plaque and its role in interventional cardiology, Handbook of the Vulnerable Plaque defines vulnerable plaque, explains how it can be detected, and discusses the characteristics of possible candidates for vulnerable plaque. The book introduces the epidemiology, genetic determination, biology, and pathology of vulnerable plaques. Subsequent chapters on detection and diagnosis review biomarkers, MRI, intravascular thermography, intravascular ultrasound, and optical coherence tomography. It covers possible treatment options such as drug therapy, photodynamic therapy, and drug-eluting stents and concludes with chapters describing industry representation and device selection. An instructional tool, the handbook helps you hone your diagnostic capabilities and provides prevention and treatment strategies to reduce the incidence of acute coronary syndrome, acute myocardial infarction, and sudden cardiac death.

Since publication of the First Edition, advances in the diagnosis and prevention and treatment strategies of the vulnerable plaque have necessitated this greatly expanded second edition. With several new chapters covering mainly diagnostic and treatment options, The Handbook of the Vulnerable Plaque will remain the benchmark text for all interventional cardiologists treating vulnerable patients by providing the physician with comprehensive insight into the world of the vulnerable plaque.

Since publication of the First Edition, advances in the diagnosis and prevention and treatment strategies of the vulnerable plaque have necessitated this greatly expanded second edition. With several new chapters covering mainly diagnostic and treatment options, The Handbook of the Vulnerable Plaque will remain the benchmark text for all interventional cardiologists treating vulnerable patients by providing the physician with comprehensive insight into the world of the vulnerable plaque.

This textbook is a readily accessible educational tool for all fellows undertaking subspecialty training in interventional cardiology, while also serving as a refresher to early career interventional cardiologists. The key objective is to equip the reader with an evidence-based expert-led resource focussed primarily on pre-procedural planning, peri-procedural decision-making, and the salient technical aspects of performing safe and effective coronary intervention, the intention being to support the therapeutic decision-making process in the emergency room, coronary care unit or cath lab in order to optimize patient outcome. The Interventional Cardiology Training Manual provides readers with a step-by-step guide to the basic principles underpinning coronary intervention and facilitates rapid access to best practice from the experts, presented in a pragmatic, digestible and concise format. Uniquely, each chapter has been written in a heart center-specific manner, affording the reader an opportunity to learn how individual institutions perform a specific procedure, which algorithms and guidelines they follow and what evidence they draw on to instigate the best possible care for their patients.

The management of non-ST segment elevation acute coronary syndromes(NSTE-ACS) has rapidly evolved over the last few years and manyguidelines have been provided and already updated. This book isbased on the latest ESC Guidelines and reports the currentknowledge in NSTE-ACS, together with the most recent therapeuticoptions and the different strategies that can be applied accordingto the clinical status of patients. International experts address the different aspects of NSTE-ACSand bring useful information to clinicians, interventionalists andsurgeons involved in the difficult management of thesepatients. The ESC Education Series This book is part of the ESC Education Series. The series isdesigned to provide medical professionals with the latestinformation about the understanding, diagnosis and management ofcardiovascular diseases. Where available, managementrecommendations are based on the established European Guidelines,which encompass the best techniques to use with each cardiacdisease. Throughout the series, the leading international opinionleaders have been chosen to edit and contribute to the books. Theinformation is presented in a succinct and accessible format with aclinical focus.

Nanomedicine is defined as the application of nanobiotechnology in clinical medicine, which is currently being used to research the pathomechanism of disease, refine molecular diagnostics, and aid in the discovery, development, and delivery of drugs. In The Handbook of Nanomedicine, Third Edition, Prof. Kewal K. Jain updates, reorganizes, and replaces information in the comprehensive second edition in order to capture the most recent advances in this dynamic field. Important components of nanomedicine such as drug delivery via nanobiotechnology and nanopharmaceuticals as well as nanooncology, where the greatest number of advances are occurring, are covered extensively. As this text is aimed at nonmedical scientists, pharmaceutical personnel, as well as physicians, descriptions of the technology involved and other medical terminology are kept as clear and simple as possible. In depth and cutting-edge, The Handbook of Nanomedicine, Third Edition informs its readers of the ever-growing field of nanomedicine, destined to play a significant role in the future of healthcare.

Given that for centuries, the standard tool to understand diseases in tissues was the microscope and that its major limitation was that only excised tissue could be used, recent technology now permits the examination of diseased tissue in vivo. Optical coherence tomography (OCT) has promising potential when applied to coronary artery disease. OCT h